Provided by Tiger Trade Technology Pte. Ltd.

ResMed

225.98
+5.292.40%
Volume:1.13M
Turnover:255.41M
Market Cap:31.86B
PE:21.67
High:228.75
Open:222.27
Low:221.83
Close:220.69
52wk High:284.87
52wk Low:180.27
Shares:141.00M
Float Shares:140.00M
Volume Ratio:1.11
T/O Rate:0.81%
Dividend:2.40
Dividend Rate:1.06%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.84
PE(LYR):21.67

Loading ...

Statement of Changes in Beneficial Ownership-RMD.N

Reuters
·
Sep 07

ResMed Director Peter C. Farrell Disposes of 970 Common Shares Worth $227,688.10

Reuters
·
Sep 04

Morgan Stanley Adjusts Price Target on ResMed to $225 From $227, Keeps Equalweight Rating

MT Newswires Live
·
Sep 03

Is ResMed (RMD) Below Fair Value On The MatrixCare Sale?

Simply Wall St.
·
Sep 02

Resmed Inc.-Accelerated Share Repurchase Agreement Announcement

THOMSON REUTERS
·
Sep 02

ResMed Launches $450 Million Accelerated Share Buyback With Citibank

MT Newswires Live
·
Sep 02

ResMed to Buy Back $450M in Stock Under Accelerated Share Repurchase Agreement

Dow Jones
·
Sep 02

ResMed Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Sep 02

Resmed - to Fund Share Repurchase with Matrixcare Sale Proceeds and Cash on Hand - SEC Filing

THOMSON REUTERS
·
Sep 02

Resmed - Enters Accelerated Share Repurchase Agreement to Repurchase $450 Mln of Common Stock - SEC Filing

THOMSON REUTERS
·
Sep 02

Resmed - Final Settlement of Asr Agreement Scheduled for December 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

Resmed Inc Stock (RMD) Moved Down by 3.25% on Sep 1: Facts Behind the Movement

TradingKey
·
Sep 02

ResMed completes divestment of MatrixCare to Frazier Healthcare Partners

TIPRANKS
·
Sep 01

ResMed Price Target Raised to $267.00/Share from $255.00 by Keybanc

Dow Jones
·
Aug 31

KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating

MT Newswires Live
·
Aug 31

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 29

Lr 1.15.3 Compliance-Rmd.n

Reuters
·
Aug 28

ResMed CEO Farrell, CFO Bloomer to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 28

ResMed Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Aug 26

ResMed Tests Wearable PAP Device, Signaling Next Wave of Sleep Apnea Innovation

TIPRANKS
·
Aug 26